ZURICH--(BUSINESS WIRE)--VirtaMed has announced a partnership with Ferring Pharmaceuticals to expand global access to simulation training for embryo transfers. The extended program is scheduled to ...
One of the first documents patients sign when starting in vitro fertilization asks them to consider the very end of their treatment: What would they like to do with extra embryos, if they have any?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback